Work

Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

Year: 2021

Type: article

Study design: Observational Study

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2021.04.045

Authors: Helen Dearden, Lewis Au, Daniel Y. Wang, Lisa Zimmer, Zeynep Eroglu, Jessica L. Smith, Marcello Cuvietto, Chloe Khoo, Victoria Atkinson, Serigne Lo, Georgina V. Long, Shahneen Sandhu, Paolo A. Ascierto, Matteo S. Carlino, Douglas B. Johnson, James Larkin, Alexander M. Menzies

Institutions: The University of Sydney, Melanoma Institute Australia, Royal Marsden NHS Foundation Trust, Vanderbilt University Medical Center, Essen University Hospital, University of Duisburg-Essen, Moffitt Cancer Center, Westmead Hospital, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Peter MacCallum Cancer Centre, The University of Queensland, Greenslopes Private Hospital, Princess Alexandra Hospital, Royal North Shore Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3173406294

FWCI: 1.82

Cites: 22

Cited by: 31

Related to: 10